COMP <GO>
PSIX vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Power Solutions International Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PSIX 6
— TMO 5
■ METRIC PARITY
LAST: $48.38 (-0.41%) • MKT CAP: $1.12B
options-implied-move
—
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PSIX VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PSIX | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 63.10% | 9.30% | +53.80 | PSIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.8x | 30.4x | -20.60 | PSIX | /valuation <GO> |
| Free Cash Flow Yield | 2.16% | 2.40% | -0.24 | TMO | /fcf-yield <GO> |
| Operating Margin | 15.20% | 17.40% | -2.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | 15.80% | 15.10% | +0.70 | PSIX | /net-margins <GO> |
| Revenue Growth (YoY) | 51.80% | 3.90% | +47.90 | PSIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.91 | 4.50 | +1.41 | PSIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.5 | 62.9 | -15.41 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.2x | 36.3x | -28.10 | PSIX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.12B | $262.22B | -$261.10B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PSIX REV | TMO REV | PSIX GROSS % | TMO GROSS % | PSIX FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $722.4M | $44.56B | 25.6% | — | $24.1M | $6.29B |
| FY 2024 | $476.0M | $42.88B | 29.5% | — | $62.4M | $7.27B |
| FY 2023 | $459.0M | $42.86B | — | — | $70.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PSIX // BETA —
TMO // BETA 0.94